查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628867

生物共軛市場，按類型、按技術、按產品、按生物共軛類型、按應用、按治療領域、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Bioconjugation Market, By Type, By Technique, By Offering, By Bioconjugation Type, By Application, By Therapeutic Area, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年生物共軛市場規模為51.2232億美元，2024年至2032年複合年成長率為15.2%。

生物共軛市場-市場動態

抗體藥物偶聯物（ADC）需求不斷成長，推動市場需求

ADC 是生物共軛的關鍵應用，由於其標靶癌症療法，預計將出現強勁成長。此外，生物治療藥物在慢性疾病治療的廣泛應用也促進了生物共軛研究。然而，先進的生物共軛技術需要大量的財務投資，限制了小公司的可及性。相反，新穎的結合工具提高了效率，鼓勵在診斷和個人化醫療中更廣泛的應用。此外，增加資金支持研發，為生物共軛市場成長創造新途徑。

生物共軛市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 15.2% 左右的複合年成長率成長

根據類型細分，預計天然生物共軛將在 2023 年顯示最大的市場佔有率

從技術細分來看，2023年醯胺鍵形成為主導類型

從產品細分來看，2023年服務業是主導類型

基於生物共軛類型細分，蛋白質生物共軛是2023年的主導類型

從應用細分來看，治療型是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

生物共軛市場-細分分析：

全球生物共軛市場根據類型、技術、產品、生物共軛類型、應用、治療領域、最終用戶和地區進行細分。

市場依類型分為兩類：合成生物結合物和天然生物結合物。由於天然生物共軛物在生物製劑和藥物開發中的廣泛應用，具有高特異性和與生物系統的兼容性，預計將主導生物共軛市場。

根據技術，市場分為五類：醯胺鍵形成、點擊化學、生物正交反應、酵素法以及硫醇-馬來醯亞胺偶聯。醯胺鍵形成領域在市場中佔據主導地位，並可能在預測期內保持其主導地位。這是由於它廣泛用於連接生物分子以進行治療和診斷應用。其穩定性和效率使其受到廣泛的青睞。

生物共軛市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

生物共軛市場-競爭格局：

在對標靶治療和藥物傳遞創新的需求不斷成長的推動下，生物結合市場出現了新技術的研發投資、擴大應用的合作夥伴關係以及透過先進的結合技術實現產品差異化等策略。公司專注於最佳化連結器和有效負載，以提高功效和安全性。此外，市場強調監管合規性和擴大製造能力，以滿足生物製藥和診斷領域不斷成長的需求。這些策略共同增強了市場競爭力，並促進了下一代治療解決方案的發展。

最新進展：

2024 年 11 月，Lonza 宣布正在擴建位於瑞士菲斯普的生物共軛工廠，增加兩個 1,200 L 製造套件和基礎設施，創造 200 個工作機會。預計將於 2028 年開始營運。

2024 年 3 月，Abzena 宣布正在擴大位於賓州布里斯託的生物共軛物生產基地，投資 500 萬美元購買新設備、升級設施和增強實驗室空間，從而提高生物製藥計畫的能力。

目錄

第1章：生物共軛市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的生物共軛市場片段
    • 生物共軛市場技術片段
    • 生物共軛市場片段（依產品分類）
    • 以生物共軛類型分類的生物共軛市場片段
    • 按應用分類的生物共軛市場片段
    • 按治療領域分類的生物共軛市場片段
    • 最終用戶的生物共軛市場片段
    • 按國家/地區分類的生物共軛市場片段
    • 按地區分類的生物共軛市場片段
  • 競爭洞察

第 3 章：生物共軛主要市場趨勢

  • 生物共軛市場促進因素
    • 市場促進因素的影響分析
  • 生物共軛市場限制
    • 市場限制影響分析
  • 生物共軛市場機會
  • 生物共軛市場未來趨勢

第 4 章：生物結合產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：生物結合市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：生物結合市場格局

  • 2023 年生物共軛市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：生物共軛市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 天然生物結合物
    • 合成生物結合物

第 8 章：生物共軛市場 - 依技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 醯胺鍵的形成
    • 點擊化學
    • 生物正交反應
    • 硫醇-馬來醯亞胺偶聯
    • 酵素法

第 9 章：生物結合市場 - 透過提供

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 試劑和試劑盒
    • 服務
      • ADC 製程開發
      • 原料藥製造
      • 分析開發
      • 早期開發生物共軛服務
      • 靶向劑或載體蛋白服務
      • 有效負載和鏈接器製造

第 10 章：生物共軛市場 - 依生物共軛類型

  • 概述
    • 按生物共軛類型分類的細分市場佔有率分析
    • 寡核苷酸生物共軛
      • 單股寡核苷酸
      • 雙股寡核苷酸
    • 聚合物生物共軛
    • 肽生物共軛
    • 蛋白質生物共軛

第 11 章：生物共軛市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 診斷
    • 治療性
      • 疫苗
      • 單株抗體
      • 抗生素
    • 研究與開發

第 12 章：生物共軛市場 - 按治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 傳染病
    • 免疫學
    • 心血管疾病
    • 腫瘤學

第 13 章：生物共軛市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 生技公司
    • 學術研究機構
    • 製藥公司
    • 合約研究組織

第 14 章：生物結合市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物共軛主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模與預測（按產品分類）
    • 北美市場規模和預測（按生物共軛類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模與預測（按治療領域）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物共軛主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模與預測（按產品分類）
    • 歐洲市場規模和預測（按生物共軛類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按治療領域）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生物共軛主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（按產品分類）
    • 亞太地區市場規模和預測（按生物共軛類型）
    • 亞太地區市場規模與預測（按應用）
    • 按治療領域分類的亞太市場規模和預測
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物共軛主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按產品分類）
    • 拉丁美洲市場規模和預測（按生物共軛類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按治療領域）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生物共軛主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按產品分類）
    • 中東和非洲市場規模及預測（按生物共軛類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按治療領域）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 15 章：主要供應商分析 - 生物共軛產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • AbbVie Inc.
    • Abcam plc
    • Abzena Limited
    • Agilent Technologies, Inc.
    • AstraZeneca PLC
    • Biocon Limited
    • Bio-Techne Corporation
    • Boehringer Ingelheim GmbH
    • Charles River Laboratories International, Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche AG
    • Innovagen AB
    • Lonza Group AG
    • Johnson & Johnson Services Inc.
    • Merck KGaA
    • Sanofi SA
    • Pfizer Inc.
    • Sartorius AG
    • Sutro Biopharma, Inc.
    • Sorrento Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co., Ltd.
    • Others

第 16 章：360 度分析師視角

第 17 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4390

REPORT HIGHLIGHT

Bioconjugation market size was valued at USD 5,122.32 Million in 2023, expanding at a CAGR of 15.2% from 2024 to 2032.

Bioconjugation is the process of chemically linking two biomolecules, such as proteins, antibodies, or nucleic acids, to enhance their functionality or specificity. This technique is widely applied in drug development, diagnostics, and imaging. By attaching therapeutic agents or markers to biomolecules, bioconjugation enables targeted delivery, improved stability, and reduced side effects. It is a cornerstone in developing antibody-drug conjugates, biosensors, and personalized medicine, significantly advancing biotherapeutics and biomedical research.

Bioconjugation Market- Market Dynamics

Rising demand for antibody-drug conjugates (ADC) growth to propel market demand

ADCs, a critical application of bioconjugation, are expected to witness strong growth due to their targeted cancer therapies. Besides, expanding applications of biotherapeutics in treating chronic diseases boost bioconjugation research. However, advanced bioconjugation techniques demand significant financial investment, limiting accessibility for smaller firms. On the contrary, novel conjugation tools improve efficiency, encouraging broader applications in diagnostics and personalized medicine. Furthermore, increasing funding supports R&D, creating new avenues for bioconjugation market growth.

Bioconjugation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.2% over the forecast period (2024-2032)

Based on type segmentation, natural bioconjugations was predicted to show maximum market share in the year 2023

Based on technique segmentation, amide bond formation was the leading type in 2023

Based on offering segmentation, services were the leading type in 2023

Based on bioconjugation type segmentation, protein bioconjugation was the leading type in 2023

Based on application segmentation, therapeutic was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioconjugation Market- Segmentation Analysis:

The Global Bioconjugation Market is segmented on the basis of Type, Technique, Offering, Bioconjugation Type, Application, Therapeutic Area, End User, and Region.

The market is divided into two categories based on Type: synthetic bioconjugates and natural bioconjugates. The natural bioconjugates segment is expected to dominate the bioconjugation market due to its widespread application in biologics and drug development, offering high specificity and compatibility with biological systems.

The market is divided into five categories based on Technique: amide bond formation, click chemistry, bio-orthogonal reactions, and enzymatic methods, and thiol-maleimide coupling. The amide bond formation sector dominates the market and is likely to maintain its dominance during the forecast period. This is due to its extensive use in linking biomolecules for therapeutic and diagnostic applications. Its stability and efficiency make it widely preferred.

Bioconjugation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bioconjugation Market- Competitive Landscape:

Driven by the increasing demand for targeted therapies and drug delivery innovations, the bioconjugation market sees strategies like R&D investments for novel technologies, partnerships to expand applications, and product differentiation through advanced conjugation techniques. Companies focus on optimizing linkers and payloads for better efficacy and safety. Additionally, the market emphasizes regulatory compliance and scaling manufacturing capabilities to meet growing demands in biopharmaceuticals and diagnostics. These strategies collectively enhance market competitiveness and enable the development of next-generation therapeutic solutions.

Recent Developments:

In November 2024, Lonza announced that it is expanding its bioconjugation facility in Visp, Switzerland, adding two 1,200 L manufacturing suites and infrastructure, creating 200 jobs. Operations are expected to begin in 2028.

In March 2024, Abzena announced that it is expanding its Bristol, PA bioconjugate manufacturing site with a $5 million investment in new equipment, upgraded facilities, and enhanced laboratory space, boosting biopharmaceutical program capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOCONJUGATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Abcam plc
  • Abzena Limited
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Biocon Limited
  • Bio-Techne Corporation
  • Boehringer Ingelheim GmbH
  • Charles River Laboratories International, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG
  • Innovagen AB
  • Lonza Group AG
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Sanofi S.A.
  • Pfizer Inc.
  • Sartorius AG
  • Sutro Biopharma, Inc.
  • Sorrento Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Others

GLOBAL BIOCONJUGATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural Bioconjugates
  • Synthetic Bioconjugates

GLOBAL BIOCONJUGATION MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Amide Bond Formation
  • Click Chemistry
  • Bio-orthogonal Reactions
  • Thiol-Maleimide Coupling
  • Enzymatic Methods

GLOBAL BIOCONJUGATION MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Services
  • ADC Process Development
  • Drug Substance Manufacturing
  • Analytical Development
  • Early Development Bioconjugate Services
  • Targeting Agent or Carrier Protein Services
  • Payload & Linker Manufacturing

GLOBAL BIOCONJUGATION MARKET, BY BIOCONJUGATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Oligonucleotide Bioconjugation
  • Single-stranded Oligonucleotides
  • Double-stranded Oligonucleotides
  • Polymer Bioconjugation
  • Peptide Bioconjugation
  • Protein Bioconjugation

GLOBAL BIOCONJUGATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutic
  • Vaccines
  • Monoclonal Antibodies
  • Antibiotics
  • Research & Development

GLOBAL BIOCONJUGATION MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Immunology
  • Cardiovascular Disorders
  • Oncology

GLOBAL BIOCONJUGATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology Companies
  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Contract Research Organizations

GLOBAL BIOCONJUGATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioconjugation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioconjugation Market Snippet by Type
    • 2.1.2. Bioconjugation Market Snippet by Technique
    • 2.1.3. Bioconjugation Market Snippet by Offering
    • 2.1.4. Bioconjugation Market Snippet by Bioconjugation Type
    • 2.1.5. Bioconjugation Market Snippet by Application
    • 2.1.6. Bioconjugation Market Snippet by Therapeutic Area
    • 2.1.7. Bioconjugation Market Snippet by End User
    • 2.1.8. Bioconjugation Market Snippet by Country
    • 2.1.9. Bioconjugation Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioconjugation Key Market Trends

  • 3.1. Bioconjugation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioconjugation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioconjugation Market Opportunities
  • 3.4. Bioconjugation Market Future Trends

4. Bioconjugation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioconjugation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioconjugation Market Landscape

  • 6.1. Bioconjugation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioconjugation Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Natural Bioconjugates
    • 7.1.3. Synthetic Bioconjugates

8. Bioconjugation Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
    • 8.1.2. Amide Bond Formation
    • 8.1.3. Click Chemistry
    • 8.1.4. Bio-orthogonal Reactions
    • 8.1.5. Thiol-Maleimide Coupling
    • 8.1.6. Enzymatic Methods

9. Bioconjugation Market - By Offering

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Offering, 2023 & 2032 (%)
    • 9.1.2. Reagents & Kits
    • 9.1.3. Services
      • 9.1.3.1. ADC Process Development
      • 9.1.3.2. Drug Substance Manufacturing
      • 9.1.3.3. Analytical Development
      • 9.1.3.4. Early Development Bioconjugate Services
      • 9.1.3.5. Targeting Agent or Carrier Protein Services
      • 9.1.3.6. Payload & Linker Manufacturing

10. Bioconjugation Market - By Bioconjugation Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Bioconjugation Type, 2023 & 2032 (%)
    • 10.1.2. Oligonucleotide Bioconjugation
      • 10.1.2.1. Single-stranded Oligonucleotides
      • 10.1.2.2. Double-stranded Oligonucleotides
    • 10.1.3. Polymer Bioconjugation
    • 10.1.4. Peptide Bioconjugation
    • 10.1.5. Protein Bioconjugation

11. Bioconjugation Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 11.1.2. Diagnostics
    • 11.1.3. Therapeutic
      • 11.1.3.1. Vaccines
      • 11.1.3.2. Monoclonal Antibodies
      • 11.1.3.3. Antibiotics
    • 11.1.4. Research & Development

12. Bioconjugation Market - By Therapeutic Area

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 12.1.2. Infectious Diseases
    • 12.1.3. Immunology
    • 12.1.4. Cardiovascular Disorders
    • 12.1.5. Oncology

13. Bioconjugation Market - By End User

  • 13.1. Overview
    • 13.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 13.1.2. Biotechnology Companies
    • 13.1.3. Academic & Research Institutions
    • 13.1.4. Pharmaceutical Companies
    • 13.1.5. Contract Research Organizations

14. Bioconjugation Market- By Geography

  • 14.1. Introduction
    • 14.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 14.2. North America
    • 14.2.1. Overview
    • 14.2.2. Bioconjugation Key Manufacturers in North America
    • 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.2.6. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.2.7. North America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.2.9. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.2.10. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.2.11. U.S.
      • 14.2.11.1. Overview
      • 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.11.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.11.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.11.5. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.11.6. U.S. Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.11.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.11.8. U.S. Market Size and Forecast, By Bioconjugation Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.11.9. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.11.10.
    • 14.2.12. Canada
      • 14.2.12.1. Overview
      • 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.12.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.12.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.12.5. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.12.6. Canada Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.12.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.12.8. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.12.9. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.12.10.
  • 14.3. Europe
    • 14.3.1. Overview
    • 14.3.2. Bioconjugation Key Manufacturers in Europe
    • 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.3.6. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.3.7. Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.3.9. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.3.10. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.11. Germany
      • 14.3.11.1. Overview
      • 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.11.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.11.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.11.5. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.11.6. Germany Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.11.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.11.8. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.11.9. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.12. Italy
      • 14.3.12.1. Overview
      • 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.12.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.12.5. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.12.6. Italy Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.12.8. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.12.9. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.13. United Kingdom
      • 14.3.13.1. Overview
      • 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.13.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.13.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.13.5. United Kingdom Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.13.6. United Kingdom Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.13.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.13.8. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.13.9. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.14. France
      • 14.3.14.1. Overview
      • 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.14.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.14.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.14.5. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.14.6. France Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.14.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.14.8. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.14.9. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.15. Russia
      • 14.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.15.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.15.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.15.4. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.15.5. Russia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.15.7. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.15.8. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.16. Netherlands
      • 14.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.16.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.16.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.16.4. Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.16.5. Netherlands Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.16.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.16.7. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.16.8. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.17. Sweden
      • 14.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.17.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.17.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.17.4. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.17.5. Sweden Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.17.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.17.7. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.17.8. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.18. Poland
      • 14.3.18.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.18.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.18.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.18.4. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.18.5. Poland Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.18.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.18.7. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.18.8. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.19. Rest of Europe
      • 14.3.19.1. Overview
      • 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.19.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.19.5. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.19.6. Rest of the Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.19.8. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.19.9. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.4. Asia Pacific (APAC)
    • 14.4.1. Overview
    • 14.4.2. Bioconjugation Key Manufacturers in Asia Pacific
    • 14.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.4.6. Asia Pacific Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.4.7. Asia Pacific Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.4.9. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.4.10. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.11. India
      • 14.4.11.1. Overview
      • 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.11.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.11.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.11.5. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.11.6. India Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.11.8. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.11.9. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.12. China
      • 14.4.12.1. Overview
      • 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.12.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.12.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.12.5. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.12.6. China Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.12.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.12.8. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.12.9. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.13. Japan
      • 14.4.13.1. Overview
      • 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.13.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.13.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.13.5. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.13.6. Japan Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.13.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.13.8. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.13.9. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.14. South Korea
      • 14.4.14.1. Overview
      • 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.14.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.14.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.14.5. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.14.6. South Korea Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.14.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.14.8. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.14.9. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.15. Australia
      • 14.4.15.1. Overview
      • 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.15.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.15.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.15.5. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.15.6. Australia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.15.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.15.8. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.15.9. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.16. Thailand
      • 14.4.16.1. Overview
      • 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.16.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.16.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.16.5. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.16.6. Thailand Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.16.8. hailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.16.9. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.17. Indonesia
      • 14.4.17.1. Overview
      • 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.17.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.17.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.17.5. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.17.6. Indonesia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.17.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.17.8. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.17.9. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.18. Philippines
      • 14.4.18.1. Overview
      • 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.18.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.18.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.18.5. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.18.6. Philippines Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.18.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.18.8. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.18.9. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.19. Rest of APAC
      • 14.4.19.1. Overview
      • 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.19.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.19.5. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.19.6. Rest of APAC Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.19.8. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.19.9. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.5. Latin America
    • 14.5.1. Overview
    • 14.5.2. Bioconjugation Key Manufacturers in Latin America
    • 14.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.5.6. Latin America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.5.7. Latin America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.5.9. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.5.10. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.11. Brazil
      • 14.5.11.1. Overview
      • 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.11.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.11.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.11.5. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.11.6. Brazil Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.11.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.11.8. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.11.9. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.12. Mexico
      • 14.5.12.1. Overview
      • 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.12.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.12.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.12.5. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.12.6. Mexico Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.12.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.12.8. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.12.9. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.13. Argentina
      • 14.5.13.1. Overview
      • 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.13.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.13.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.13.5. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.13.6. Argentina Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.13.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.13.8. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.13.9. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.14. Colombia
      • 14.5.14.1. Overview
      • 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.14.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.14.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.14.5. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.14.6. Colombia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.14.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.14.8. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.14.9. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.15. Rest of LATAM
      • 14.5.15.1. Overview
      • 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.15.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.15.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.15.5. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.15.6. Rest of LATAM Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.15.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.15.8. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.15.9. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.6. Middle East and Africa
    • 14.6.1. Overview
    • 14.6.2. Bioconjugation Key Manufacturers in Middle East and Africa
    • 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.6.6. Middle East and Africa Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.6.7. Middle East and Africa Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.6.9. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.6.10. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.11. Saudi Arabia
      • 14.6.11.1. Overview
      • 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.11.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.11.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.11.5. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.11.6. Saudi Arabia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.11.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.11.8. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.11.9. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.12. United Arab Emirates
      • 14.6.12.1. Overview
      • 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.12.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.12.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.12.5. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.12.6. United Arab Emirates Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.12.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.12.8. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.12.9. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.13. Israel
      • 14.6.13.1. Overview
      • 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.13.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.13.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.13.5. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.13.6. Israel Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.13.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.13.8. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.13.9. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.14. Turkey
      • 14.6.14.1. Overview
      • 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.14.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.14.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.14.5. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.14.6. Turkey Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.14.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.14.8. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.14.9. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.15. Algeria
      • 14.6.15.1. Overview
      • 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.15.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.15.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.15.5. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.15.6. Algeria Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.15.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.15.8. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.15.9. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.16. Egypt
      • 14.6.16.1. Overview
      • 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.16.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.16.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.16.5. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.16.6. Egypt Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.16.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.16.8. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.16.9. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.17. Rest of MEA
      • 14.6.17.1. Overview
      • 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.17.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.17.5. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.17.6. Rest of MEA Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.17.8. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.17.9. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Bioconjugation Industry

  • 15.1. Competitive Dashboard
    • 15.1.1. Competitive Benchmarking
    • 15.1.2. Competitive Positioning
  • 15.2. Company Profiles
    • 15.2.1. AbbVie Inc.
    • 15.2.2. Abcam plc
    • 15.2.3. Abzena Limited
    • 15.2.4. Agilent Technologies, Inc.
    • 15.2.5. AstraZeneca PLC
    • 15.2.6. Biocon Limited
    • 15.2.7. Bio-Techne Corporation
    • 15.2.8. Boehringer Ingelheim GmbH
    • 15.2.9. Charles River Laboratories International, Inc.
    • 15.2.10. Bristol-Myers Squibb Company
    • 15.2.11. Eli Lilly and Company
    • 15.2.12. GlaxoSmithKline plc
    • 15.2.13. F. Hoffmann-La Roche AG
    • 15.2.14. Innovagen AB
    • 15.2.15. Lonza Group AG
    • 15.2.16. Johnson & Johnson Services Inc.
    • 15.2.17. Merck KGaA
    • 15.2.18. Sanofi S.A.
    • 15.2.19. Pfizer Inc.
    • 15.2.20. Sartorius AG
    • 15.2.21. Sutro Biopharma, Inc.
    • 15.2.22. Sorrento Therapeutics, Inc.
    • 15.2.23. Thermo Fisher Scientific Inc.
    • 15.2.24. WuXi AppTec Co., Ltd.
    • 15.2.25. Others

16. 360 Degree Analyst View

17. Appendix

  • 17.1. Research Methodology
  • 17.2. References
  • 17.3. Abbreviations
  • 17.4. Disclaimer
  • 17.5. Contact Us